Image

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Researching MORF-057 for moderate to severe Crohn's disease symptoms.

Recruiting
18-85 years
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study tests a medicine called MORF-057 for adults with Crohn's Disease (CD), which is when your intestines get swollen and hurt a lot. The study has two parts: a 14-week Induction Period where you might get MORF-057 or a placebo (a fake pill), and then a 38-week Maintenance Period where everyone gets MORF-057. After 52 weeks, you can continue for another year if you want. A placebo is a pill that looks like the real medicine but doesn't contain any medicine. This study is double-blind, meaning neither you nor the doctors will know if you're getting the real medicine or the placebo during the induction period.

  • Duration: The study lasts for up to 104 weeks (2 years).
  • Visits: You need to attend regular visits for check-ups and tests.
  • Eligibility: Must have moderate to severe CD and meet specific health criteria.
Print
Study details
    Inflammatory Bowel Diseases
    Crohn's Disease

NCT06226883

Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)

17 October 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race*
Are you a healthy volunteer
Ethnicity*
Are you a healthy volunteer
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.